Ransom strengthens board for aquisition plans
two non-executive directors, to help boost its brand development
strategy, as it continues to acquire consumer health brands.
UK-based natural healthcare company William Ransom has appointed two non-executive directors, to help boost its brand development and finance strategy.
The company, which manufactures plant extracts for the healthcare, food and drink and cosmetic industries, is seeking to become the UK's leading natural product-based consumer healthcare business.
In April this year Ransom bought Pavacol-D, an OTC cough syrup brand, from Germany's Boehringer Ingelheim. This followed the purchase of a set of Roche consumer brands last year and Cariad Aromatherapy in 2001. The company is aiming to continue to acquire healthcarebrands that no longer fit within enlarged multi-nationalpharmaceutical businesses.
Ransom said today it has appointed Jacqueline Paterson, previously head of Beauty and Lingerie at Marks & Spencer, and William Nabarro, recently retired as vice-chairman of KPMG Corporate Finance, to join its board with effect from today.
Sales for the year to 31 March 2003 grew by 38 per cent to £14.725 million (€21.20m), returning the company to a profit before goodwill amortisation of £0.563m.
